The partnership aims to deploy AI capabilities that automatically analyse X-ray and CT images to assist radiologists.

Sanghnomics: The government’s move to curb 10-minute deliveries reflects a broader policy shift towards safeguarding gig ...

Amidst pressure from RSS affiliates, the government’s move is a recalibration of India’s digital commerce ecosystem to ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

Harald Hampel is recognized as an influential leader in neuroscience, and will bring expertise in Alzheimer's disease to BMS.

Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. | Microsoft ...

Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology ...

Microsoft (MSFT) and pharmaceutical concern Bristol Myers Squibb (BMY) are partnering on a new artificial intelligence (A.I.) ...

A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

Bristol Myers Squibb (NYSE:BMY) said on Tuesday that it has entered into a partnership with Microsoft (NASDAQ:MSFT) to ...

The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.